Predictive Oncology Inc. (POAI) Reports Q1 Loss of $0.93
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Predictive Oncology Reports First Quarter 2020 Financial Results, Provides Business Update
June 8, 2020 4:16 PM EDTCancerQuest 2020 Study on Schedule for Completion in Q2 2020
NEW YORK, June 08, 2020 (GLOBE NEWSWIRE) -- Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (AI) to personalized medicine and drug discovery, today reported financial results for the quarter ended March 31, 2020 and provided a business update.
Financial and Business Highlights
Continued initial study to sequence ovarian tumors and validate reach back process; study is on schedule to be completed in the second quarter of 2020Developing a... More